Clinical Trial Update: Open-Label Study of Bioavailability of E2006 Tablet Versus Capsule Formulations [Phase 1]

View source ↗

Summary

Open-label Phase 1 study evaluating the relative bioavailability of E2006 tablet versus capsule formulations in individuals with insomnia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• E2006

Snippet

Sponsor: Eisai Inc. | Conditions: Insomnia | Phase 1 | Status: COMPLETED